Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
UnitedHealth Group Inc ha un obiettivo di prezzo di consenso pari a $414.19, stabilito in base alle ultime valutazioni degli analisti di 27. Le ultime 3 valutazioni degli analisti sono state rilasciate da Jefferies, Goldman Sachs y JP Morgan il octubre 17, 2025, octubre 14, 2025 y octubre 9, 2025. Con un obiettivo di prezzo medio di $413.33 tra le Jefferies, Goldman Sachs y JP Morgan, c'è un implicito 13.50% upside per UnitedHealth Group Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Jefferies
Goldman Sachs
JP Morgan
Mizuho
Barclays
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para UnitedHealth Group
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/17/2025 | 12.31% | Jefferies | $317 → $409 | Maintains | Buy | |||
10/14/2025 | 11.49% | Goldman Sachs | → $406 | Initiates | → Buy | |||
10/09/2025 | 16.7% | JP Morgan | $310 → $425 | Maintains | Overweight | |||
10/09/2025 | 18.08% | Mizuho | $300 → $430 | Maintains | Outperform | |||
10/09/2025 | 5.99% | Barclays | $352 → $386 | Maintains | Overweight | |||
10/08/2025 | 7.09% | B of A Securities | $350 → $390 | Maintains | Neutral | |||
10/08/2025 | 18.9% | Bernstein | $379 → $433 | Maintains | Outperform | |||
10/08/2025 | 9.84% | Keybanc | $350 → $400 | Maintains | Overweight | |||
10/07/2025 | 9.84% | Wells Fargo | $267 → $400 | Maintains | Overweight | |||
09/12/2025 | 8.47% | Morgan Stanley | $325 → $395 | Maintains | Overweight | |||
09/09/2025 | 0.23% | Truist Securities | $310 → $365 | Maintains | Buy | |||
09/05/2025 | 4.07% | Bernstein | $337 → $379 | Maintains | Outperform | |||
09/04/2025 | -3.34% | Barclays | $337 → $352 | Maintains | Overweight | |||
08/26/2025 | 20.82% | Cantor Fitzgerald | $440 → $440 | Reiterates | Overweight → Overweight | |||
08/20/2025 | -10.76% | Morgan Stanley | $342 → $325 | Maintains | Overweight | |||
08/18/2025 | -10.76% | B of A Securities | $290 → $325 | Maintains | Neutral | |||
08/07/2025 | -17.62% | Mizuho | $350 → $300 | Maintains | Outperform | |||
08/06/2025 | -14.88% | JP Morgan | $418 → $310 | Maintains | Overweight | |||
08/04/2025 | -26.68% | Wells Fargo | $306 → $267 | Maintains | Overweight | |||
07/31/2025 | -45.63% | Baird | $312 → $198 | Downgrade | Neutral → Underperform | |||
07/30/2025 | -21.47% | RBC Capital | $355 → $286 | Maintains | Outperform | |||
07/30/2025 | -10.76% | Oppenheimer | $400 → $325 | Maintains | Outperform | |||
07/30/2025 | -3.89% | Keybanc | $400 → $350 | Maintains | Overweight | |||
07/30/2025 | -12.95% | Piper Sandler | $353 → $317 | Maintains | Overweight | |||
07/30/2025 | -20.37% | B of A Securities | $300 → $290 | Maintains | Neutral | |||
07/29/2025 | -17.62% | B of A Securities | $350 → $300 | Maintains | Neutral | |||
07/25/2025 | -15.97% | Wells Fargo | $351 → $306 | Maintains | Overweight | |||
07/16/2025 | -5.26% | Truist Securities | $360 → $345 | Maintains | Buy | |||
07/13/2025 | -6.09% | Morgan Stanley | $374 → $342 | Maintains | Overweight | |||
07/09/2025 | -7.46% | Barclays | $350 → $337 | Maintains | Overweight | |||
06/25/2025 | 5.72% | UBS | $400 → $385 | Maintains | Buy | |||
06/20/2025 | 14.78% | JP Morgan | $405 → $418 | Maintains | Overweight | |||
06/11/2025 | -14.33% | Baird | $356 → $312 | Downgrade | Outperform → Neutral | |||
06/03/2025 | -3.07% | Piper Sandler | $552 → $353 | Maintains | Overweight | |||
06/02/2025 | -3.89% | Barclays | $362 → $350 | Maintains | Overweight | |||
06/02/2025 | 9.84% | Keybanc | $450 → $400 | Maintains | Overweight | |||
05/21/2025 | -25.86% | HSBC | $490 → $270 | Downgrade | Hold → Reduce | |||
05/20/2025 | 7.09% | Wolfe Research | $501 → $390 | Maintains | Outperform | |||
05/19/2025 | -15.42% | TD Securities | $520 → $308 | Downgrade | Buy → Hold | |||
05/19/2025 | -1.15% | Truist Securities | $580 → $360 | Reiterates | Buy → Buy | |||
05/16/2025 | -3.89% | Mizuho | $515 → $350 | Maintains | Outperform | |||
05/16/2025 | -2.52% | RBC Capital | $525 → $355 | Maintains | Outperform | |||
05/15/2025 | -0.6% | Barclays | $513 → $362 | Maintains | Overweight | |||
05/15/2025 | 11.21% | JP Morgan | $525 → $405 | Maintains | Overweight | |||
05/14/2025 | -0.6% | Deutsche Bank | $521 → $362 | Maintains | Buy | |||
05/14/2025 | 9.84% | Oppenheimer | $600 → $400 | Maintains | Outperform | |||
05/14/2025 | -3.62% | Wells Fargo | $677 → $351 | Maintains | Overweight | |||
05/14/2025 | 2.7% | Morgan Stanley | $563 → $374 | Maintains | Overweight | |||
05/14/2025 | -3.89% | B of A Securities | $560 → $350 | Downgrade | Buy → Neutral | |||
05/14/2025 | -2.24% | Baird | $510 → $356 | Maintains | Outperform | |||
05/14/2025 | 23.57% | Keybanc | $575 → $450 | Maintains | Overweight | |||
05/13/2025 | 51.58% | Piper Sandler | $552 → $552 | Maintains | Overweight | |||
05/06/2025 | 41.42% | Mizuho | $650 → $515 | Maintains | Outperform | |||
04/29/2025 | 40.04% | Baird | $640 → $510 | Maintains | Outperform | |||
04/24/2025 | 40.87% | Barclays | $560 → $513 | Maintains | Overweight | |||
04/24/2025 | 44.16% | JP Morgan | $652 → $525 | Maintains | Overweight | |||
04/23/2025 | 44.16% | RBC Capital | $655 → $525 | Maintains | Outperform | |||
04/22/2025 | 34.55% | HSBC | $595 → $490 | Downgrade | Buy → Hold | |||
04/22/2025 | 54.6% | Morgan Stanley | $664 → $563 | Maintains | Overweight | |||
04/21/2025 | 53.77% | B of A Securities | $700 → $560 | Maintains | Buy | |||
04/21/2025 | — | Argus Research | — | Downgrade | Buy → Hold | |||
04/21/2025 | 59.27% | Truist Securities | $660 → $580 | Maintains | Buy | |||
04/21/2025 | 53.77% | Barclays | $642 → $560 | Maintains | Overweight | |||
04/21/2025 | 57.89% | Keybanc | $650 → $575 | Maintains | Overweight | |||
04/21/2025 | 48.28% | Raymond James | $635 → $540 | Reiterates | Strong Buy → Strong Buy | |||
04/21/2025 | 64.76% | Oppenheimer | $640 → $600 | Maintains | Outperform | |||
04/11/2025 | 81.23% | Truist Securities | $610 → $660 | Maintains | Buy | |||
04/09/2025 | 78.49% | Mizuho | $600 → $650 | Maintains | Outperform | |||
04/08/2025 | 85.9% | Wells Fargo | $660 → $677 | Maintains | Overweight | |||
01/28/2025 | 81.23% | Wells Fargo | $694 → $660 | Maintains | Overweight | |||
01/17/2025 | 76.29% | Barclays | $655 → $642 | Maintains | Overweight | |||
01/17/2025 | 78.49% | Keybanc | $650 → $650 | Reiterates | Overweight → Overweight | |||
01/17/2025 | 92.22% | Cantor Fitzgerald | $700 → $700 | Reiterates | Overweight → Overweight | |||
01/06/2025 | 67.5% | Truist Securities | $625 → $610 | Maintains | Buy | |||
01/02/2025 | 64.76% | Piper Sandler | $605 → $600 | Maintains | Overweight | |||
12/06/2024 | 75.74% | Oppenheimer | $610 → $640 | Maintains | Outperform | |||
12/05/2024 | 85.35% | Stephens & Co. | $605 → $675 | Maintains | Overweight | |||
12/03/2024 | 71.62% | Deutsche Bank | $595 → $625 | Maintains | Buy | |||
11/27/2024 | 79.86% | Barclays | $603 → $655 | Maintains | Overweight | |||
10/22/2024 | 65.58% | Barclays | $604 → $603 | Maintains | Overweight | |||
10/18/2024 | 67.23% | TD Cowen | $601 → $609 | Maintains | Buy | |||
10/16/2024 | 78.49% | UBS | $680 → $650 | Maintains | Buy | |||
10/16/2024 | 66.13% | Stephens & Co. | $632 → $605 | Maintains | Overweight | |||
10/16/2024 | 76.84% | Cantor Fitzgerald | $591 → $644 | Maintains | Overweight | |||
10/16/2024 | 71.62% | Truist Securities | $640 → $625 | Reiterates | Buy → Buy | |||
10/16/2024 | 63.38% | RBC Capital | $615 → $595 | Maintains | Outperform | |||
10/16/2024 | 78.49% | Keybanc | $675 → $650 | Maintains | Overweight | |||
10/16/2024 | 67.5% | Morgan Stanley | $615 → $610 | Maintains | Overweight | |||
10/16/2024 | 78.49% | B of A Securities | $675 → $650 | Maintains | Buy | |||
10/11/2024 | 85.35% | Keybanc | → $675 | Initiates | → Overweight | |||
10/01/2024 | 62.29% | Cantor Fitzgerald | $591 → $591 | Reiterates | Overweight → Overweight | |||
09/20/2024 | 62.29% | Cantor Fitzgerald | $591 → $591 | Reiterates | Overweight → Overweight | |||
09/16/2024 | 62.29% | Cantor Fitzgerald | $591 → $591 | Reiterates | Overweight → Overweight | |||
09/10/2024 | 62.29% | Cantor Fitzgerald | $591 → $591 | Reiterates | Overweight → Overweight | |||
08/19/2024 | 62.29% | Cantor Fitzgerald | $591 → $591 | Reiterates | Overweight → Overweight | |||
07/23/2024 | 62.29% | Cantor Fitzgerald | $591 → $591 | Reiterates | Overweight → Overweight | |||
07/18/2024 | 86.73% | UBS | $640 → $680 | Maintains | Buy | |||
07/17/2024 | 64.76% | Argus Research | $570 → $600 | Maintains | Buy | |||
07/17/2024 | 65.03% | TD Cowen | $546 → $601 | Maintains | Buy | |||
07/17/2024 | 65.86% | Barclays | $560 → $604 | Maintains | Overweight |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de UnitedHealth Group (UNH)?
El último precio objetivo de UnitedHealth Group (NYSE:UNH) fue comunicado por Jefferies el octubre 17, 2025. La firma de analistas fijó un precio objetivo para $409.00 que espera UNH a rise dentro de 12 meses (un posible 12.31% upside). 79 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre UnitedHealth Group (UNH)?
La última calificación de analistas para UnitedHealth Group (NYSE:UNH) fue proporcionada por Jefferies, y UnitedHealth Group mantuvo su buy calificación.
¿Cuándo se produjo la última revisión al alza de UnitedHealth Group (UNH)?
No hay última actualización para UnitedHealth Group
¿Cuándo fue la última revisión a la baja de UnitedHealth Group (UNH)?
La última revisión a la baja de UnitedHealth Group Inc se produjo en julio 31, 2025, cuando Baird cambió su precio objetivo de $312 a $198 para UnitedHealth Group Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para UnitedHealth Group (UNH)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de UnitedHealth Group, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de UnitedHealth Group se registró el octubre 17, 2025, por lo que la próxima calificación estará disponible en torno al octubre 17, 2026.
¿Es correcta la calificación de los analistas sobre UnitedHealth Group (UNH)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de UnitedHealth Group (UNH) fue un mantuvo con un precio objetivo de $317.00 a $409.00. El precio actual al que cotiza UnitedHealth Group (UNH) es de $364.17, que es within del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.